Condition

Microbiome

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting4
Common interventions16
Lead sponsors shown15
Advertisement

Clinical trials

17 shown
Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant ImmunotherapyNCT07311083 · 2026-02-01
RECRUITING
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without DiarrheaNCT07264998 · 2025-12-21
RECRUITING
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIVNCT05514899 · 2023-09-01
RECRUITING
A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in ChinaNCT05445544 · 2022-10-19
RECRUITING
Supplementation of Inulin + L. Acidophilus in Elders with T2DMNCT06830824 · 2025-03-01
NOT_YET_RECRUITING
Precision Nutrition Recommendations Generated by Metataxonomic Microbiome Testing Improve Food Group Choices and Intestinal Health Indicators in an Obese Population in ColombiaNCT07492485 · 2023-07-10
COMPLETED
Inflammation in HIV/AIDS-InflammAIDSNCT07367867 · 2023-03-06
COMPLETED
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute ExacerbationNCT04865861 · 2021-05-01
UNKNOWN
Microbiome and Exacerbations in Neutrophilic AsthmaNCT04260282 · 2021-01-01
UNKNOWN
Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung CancerNCT04260295 · 2019-11-01
UNKNOWN
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and DiagnosticsNCT04136470 · 2019-04-01
UNKNOWN
Effect of Liraglutide on Microbiome in ObesityNCT04046822 · 2019-01-09
UNKNOWN
Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPDNCT04259736 · 2019-01-01
UNKNOWN
Dysbiosis Impact on Lung Disease in HIVNCT04155684 · 2018-11-01
COMPLETED
Modification of Gut Microbiota in the Treatment of Insulin Resistance: a Personalized ApproachNCT03710850 · 2018-05-01
COMPLETED
Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric SurgeryNCT03391401 · 2018-03-01
COMPLETED
Studying on the Difference Between Two Kinds of OsteomyelitisNCT04240964 · 2017-07-01
COMPLETED

Common interventions

Trial status mix

COMPLETED6
UNKNOWN6
RECRUITING4
NOT_YET_RECRUITING1

Phase mix

NA4
PHASE21
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.